DK236185A - Stabiliseret insulin-formulering - Google Patents

Stabiliseret insulin-formulering Download PDF

Info

Publication number
DK236185A
DK236185A DK236185A DK236185A DK236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A
Authority
DK
Denmark
Prior art keywords
insulin formulation
stabilized insulin
stabilized
formulation
insulin
Prior art date
Application number
DK236185A
Other languages
English (en)
Other versions
DK236185D0 (da
Inventor
Eddie Herman Massey
Theodore Arsay Sheliga
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK236185D0 publication Critical patent/DK236185D0/da
Publication of DK236185A publication Critical patent/DK236185A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK236185A 1984-05-29 1985-05-28 Stabiliseret insulin-formulering DK236185A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61435584A 1984-05-29 1984-05-29

Publications (2)

Publication Number Publication Date
DK236185D0 DK236185D0 (da) 1985-05-28
DK236185A true DK236185A (da) 1985-11-30

Family

ID=24460897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK236185A DK236185A (da) 1984-05-29 1985-05-28 Stabiliseret insulin-formulering

Country Status (5)

Country Link
EP (1) EP0166529B1 (da)
JP (1) JPS6122026A (da)
CA (1) CA1244347A (da)
DE (1) DE3576458D1 (da)
DK (1) DK236185A (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
EP0200383A3 (en) * 1985-04-15 1987-09-02 Eli Lilly And Company An improved method for administering insulin
BR8603586A (pt) * 1985-07-30 1987-03-10 Int Minerals & Chem Corp Processo para manter a fluidez de um homonio;processo para efetuar a promocao de crescimento em animais e formulacao promotora de crescimento
WO1995032219A1 (fr) * 1994-05-20 1995-11-30 Hisamitsu Pharmaceutical Co., Inc. Proteine ou polypeptide, procede et intermediaires permettant leur preparation
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co DRUG
FR2755440B1 (fr) * 1996-11-07 1999-01-15 Tuffet Sophie Procede de conservation de longue duree de molecules d'adn et conditionnement pour sa mise en oeuvre
ES2248902T3 (es) * 1998-05-06 2006-03-16 Societe Imagene Procedimiento de conservacion de larga duracion de moleculas de adn y envase para su realizacion.
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
KR101939557B1 (ko) 2008-10-17 2019-01-17 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 ｇｌｐ－1 효능제의 병용물
CN107308442B (zh) 2009-11-13 2022-10-18 赛诺菲-安万特德国有限公司 包含glp-1激动剂、胰岛素和甲硫氨酸的药物组合物
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
LT2611458T (lt) 2010-08-30 2016-12-27 Sanofi-Aventis Deutschland Gmbh Ave0010 panaudojimas gaminant vaistą, skirtą 2 tipo cukrinio diabeto gydymui
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
MX370264B (es) 2011-08-29 2019-12-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
ZA808097B (en) * 1980-12-29 1982-01-27 Lilly Co Eli Novel insulin formulations

Also Published As

Publication number Publication date
JPS6122026A (ja) 1986-01-30
EP0166529B1 (en) 1990-03-14
CA1244347A (en) 1988-11-08
EP0166529A1 (en) 1986-01-02
DK236185D0 (da) 1985-05-28
DE3576458D1 (de) 1990-04-19

Similar Documents

Publication Publication Date Title
BR8806982A (pt) Composicao estabilizada
BR8802017A (pt) Composicao estabilizada
NO2000005I1 (no) Insulin aspart
DK481585D0 (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
MX163529B (es) Composicion quimicoluminiscente
DK479685A (da) Stol
DK236185D0 (da) Stabiliseret insulin-formulering
DK162562C (da) Staldkonstruktion
IT1209615B (it) Composizione farmaceutica
DK437786D0 (da) Insulinprecursorer
DK86785D0 (da) Bromcryptinpraeparater
DK182287D0 (da) Stabiliserede peptidsoedemidler
FR2582908B3 (fr) Compositions stabilisees.
ES288629Y (es) Jeringa
DK51885A (da) Glycosylerede insulinderivater
KR860007343U (ko) 주사용 수액세트
MX163537B (es) Composicion insecticida
ES276839Y (es) Jeringuilla
BR8406387A (pt) Seringa
SE8402858D0 (sv) Ampull
SE8400444D0 (sv) Ateranvendningsbart bodunderlag
DK42483D0 (da) Stabiliserede insulinoploesninger
RO90654A2 (ro) Compozitie insecticida sinergetica
RO92144A2 (ro) Compozitie insecticida
LT2605B (lt) Insekticidinis preparatas

Legal Events

Date Code Title Description
ATS Application withdrawn